Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ULTRACEMCO.NS Stock Summary
In the News
ULTRACEMCO.NS Financial details
Company Rating
Buy
Market Cap
2782.54B
Income
64.13B
Revenue
691.52B
Book val./share
-
Cash/share
-
Dividend
38
Dividend %
0.39%
Employees
22.92K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
49.47
Forward P/E
-
PEG
-39.16
P/S
4.15
P/B
5.02
P/C
-
P/FCF
-
Quick Ratio
0.43
Current Ratio
0.83
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
222.47
EPS next Y
-
EPS next Q
-
EPS this Y
-31.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.63%
Revenue last 5Y
11.45%
Revenue Q/Q
4.55%
EPS Q/Q
38.69%
-
-
-
-
SMA20
0.03%
SMA50
-4.1%
SMA100
10.66%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
11%
ROC
0.13%
Gross Margin
84%
Oper. Margin
13%
Profit Margin
8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7300.0-10526.0
52W High
-11.04%
52W Low
+28.27%
RSI
37
Rel Volume
1.32
Avg Volume
315.92K
Volume
415.5K
Perf Week
-5.07%
Perf Month
-7.35%
Perf Quarter
14.12%
Perf Half Y
12.8%
-
-
-
-
Beta
0.496
-
-
Volatility
169.29%, 182.52%
Prev Close
-0.2%
Price
9363.95
Change
-1.12%
ULTRACEMCO.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.34K | 1.44K | 1.53K | 1.79K | 2.19K | |
Net income per share | 88.72 | 199.55 | 189.4 | 254.64 | 175.63 | |
Operating cash flow per share | 188.02 | 308.65 | 433.45 | 321.86 | 314.52 | |
Free cash flow per share | 127.51 | 249.49 | 366.72 | 127.24 | 99.48 | |
Cash per share | 84.71 | 161.26 | 456.76 | 194.9 | 292.03 | |
Book value per share | 1.03K | 1.36K | 1.53K | 1.75K | 1.88K | |
Tangible book value per share | 923.24 | 1.13K | 1.31K | 1.52K | 1.47K | |
Share holders equity per share | 1.03K | 1.36K | 1.53K | 1.75K | 1.88K | |
Interest debt per share | 887.69 | 866.09 | 770.05 | 387.77 | 412.05 | |
Market cap | 1112.4B | 935.87B | 1943.55B | 1904.27B | 2197.67B | |
Enterprise value | 1336.21B | 1164.97B | 2148.97B | 2006.05B | 2304.54B | |
P/E ratio | 45.69 | 16.26 | 35.58 | 25.93 | 43.4 | |
Price to sales ratio | 3.02 | 2.26 | 4.39 | 3.68 | 3.48 | |
POCF ratio | 21.56 | 10.51 | 15.54 | 20.51 | 24.23 | |
PFCF ratio | 31.79 | 13.01 | 18.37 | 51.89 | 76.62 | |
P/B Ratio | 3.92 | 2.39 | 4.4 | 3.78 | 4.05 | |
PTB ratio | 3.92 | 2.39 | 4.4 | 3.78 | 4.05 | |
EV to sales | 3.63 | 2.81 | 4.86 | 3.88 | 3.64 | |
Enterprise value over EBITDA | 19.28 | 12.3 | 18.35 | 17.23 | 20.71 | |
EV to operating cash flow | 25.9 | 13.09 | 17.19 | 21.61 | 25.41 | |
EV to free cash flow | 38.19 | 16.19 | 20.32 | 54.66 | 80.34 | |
Earnings yield | 0.02 | 0.06 | 0.03 | 0.04 | 0.02 | |
Free cash flow yield | 0.03 | 0.08 | 0.05 | 0.02 | 0.01 | |
Debt to equity | 0.8 | 0.59 | 0.47 | 0.2 | 0.2 | |
Debt to assets | 0.35 | 0.29 | 0.24 | 0.12 | 0.12 | |
Net debt to EBITDA | 3.23 | 2.42 | 1.75 | 0.87 | 0.96 | |
Current ratio | 0.91 | 0.86 | 1.13 | 0.87 | 0.88 | |
Interest coverage | 3 | 3.41 | 5.92 | 9.94 | 10.01 | |
Income quality | 1.46 | 1.7 | 1.59 | 1.11 | 1.22 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0.14 | 0.07 | 0.07 | 0.15 | 0.22 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.08 | 0.08 | 0.08 | 0.13 | |
Capex to operating cash flow | -0.32 | -0.19 | -0.15 | -0.6 | -0.68 | |
Capex to revenue | -0.05 | -0.04 | -0.04 | -0.11 | -0.1 | |
Capex to depreciation | -0.78 | -0.63 | -0.71 | -2.07 | -2.15 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.44K | 2.47K | 2.55K | 3.17K | 2.73K | |
ROIC | 0.06 | 0.11 | 0.09 | 0.12 | 0.08 | |
Return on tangible assets | 0.04 | 0.08 | 0.07 | 0.1 | 0.06 | |
Graham Net | -1.01K | -1.03K | -817.64 | -745 | -779.88 | |
Working capital | -11.02B | -22.1B | 27.06B | -26.75B | -27.07B | |
Tangible asset value | 253.36B | 326.23B | 376.95B | 439.11B | 423.55B | |
Net current asset value | -243.79B | -262.83B | -189.49B | -159.16B | -163.93B | |
Invested capital | 0.8 | 0.59 | 0.47 | 0.2 | 0.2 | |
Average receivables | 47.21B | 55.31B | 47.46B | 44.82B | 42.63B | |
Average payables | 26.75B | 31.73B | 41B | 52.81B | 65.36B | |
Average inventory | 34.26B | 38.67B | 40.83B | 48.07B | 61.04B | |
Days sales outstanding | 58.37 | 45.59 | 35.58 | 32.84 | 22.36 | |
Days payables outstanding | 122.62 | 150.99 | 184.25 | 198.21 | 270.86 | |
Days of inventory on hand | 154.48 | 178.89 | 157.53 | 189.17 | 248.41 | |
Receivables turnover | 6.25 | 8.01 | 10.26 | 11.12 | 16.32 | |
Payables turnover | 2.98 | 2.42 | 1.98 | 1.84 | 1.35 | |
Inventory turnover | 2.36 | 2.04 | 2.32 | 1.93 | 1.47 | |
ROE | 0.09 | 0.15 | 0.12 | 0.15 | 0.09 | |
Capex per share | -60.51 | -59.16 | -66.73 | -194.62 | -215.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 538.29 | 647.31 | 615.28 | 555.54 | 580.87 | |
Net income per share | 36.7 | 57.78 | 58.57 | 44.46 | 61.66 | |
Operating cash flow per share | 50.17 | 52.84 | 51.97 | 55.36 | 54.37 | |
Free cash flow per share | 50.17 | 52.84 | 51.97 | 55.36 | 54.37 | |
Cash per share | 0 | 292.05 | 0 | 227.31 | 0 | |
Book value per share | 0 | 1.88K | 0 | 1.95K | 0 | |
Tangible book value per share | 0 | 1.47K | 0 | 1.54K | 0 | |
Share holders equity per share | 0 | 1.88K | 0 | 1.95K | 0 | |
Interest debt per share | 7.47 | 390.18 | 7.31 | 405.7 | 9.1 | |
Market cap | 2006.56B | 2197.52B | 2391.2B | 2379.26B | 3015.62B | |
Enterprise value | 2006.56B | 2304.39B | 2391.2B | 2491.99B | 3015.62B | |
P/E ratio | 47.4 | 32.98 | 35.41 | 46.42 | 42.43 | |
Price to sales ratio | 12.93 | 11.78 | 13.48 | 14.86 | 18.01 | |
POCF ratio | 138.72 | 144.26 | 159.61 | 149.11 | 192.45 | |
PFCF ratio | 138.72 | 144.26 | 159.61 | 149.11 | 192.45 | |
P/B Ratio | 0 | 4.05 | 0 | 4.24 | 0 | |
PTB ratio | 0 | 4.05 | 0 | 4.24 | 0 | |
EV to sales | 12.93 | 12.35 | 13.48 | 15.56 | 18.01 | |
Enterprise value over EBITDA | 81.38 | 66.88 | 74.11 | 91.57 | 88.67 | |
EV to operating cash flow | 138.72 | 151.27 | 159.61 | 156.17 | 192.45 | |
EV to free cash flow | 138.72 | 151.27 | 159.61 | 156.17 | 192.45 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.2 | 0 | 0.2 | 0 | |
Debt to assets | 0 | 0.12 | 0 | 0.12 | 0 | |
Net debt to EBITDA | 0 | 3.1 | 0 | 4.14 | 0 | |
Current ratio | 0 | 0.88 | 0 | 0.83 | 0 | |
Interest coverage | 8.1 | 14.02 | 11.76 | 8.22 | 9.98 | |
Income quality | 1.37 | 0.91 | 0.89 | 1.25 | 0.88 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.13 | 0 | 0.13 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 1.57K | 0 | 1.4K | 0 | |
ROIC | 0 | 0.03 | 0 | 0.02 | 0 | |
Return on tangible assets | 0 | 0.02 | 0 | 0.02 | 0 | |
Graham Net | 0 | -779.94 | 0 | -849.93 | 0 | |
Working capital | 0 | -27.07B | 0 | -41.44B | 0 | |
Tangible asset value | 0 | 423.55B | 0 | 443.29B | 0 | |
Net current asset value | 0 | -163.93B | 0 | -175.48B | 0 | |
Invested capital | 0 | 0.2 | 0 | 0.2 | 0 | |
Average receivables | 20.24B | 19.37B | 19.37B | 19.44B | 19.44B | |
Average payables | 27.69B | 36.05B | 36.05B | 37.37B | 37.37B | |
Average inventory | 34.65B | 33.06B | 33.06B | 38.23B | 38.23B | |
Days sales outstanding | 0 | 18.69 | 0 | 21.85 | 0 | |
Days payables outstanding | 0 | 204.61 | 0 | 269.72 | 0 | |
Days of inventory on hand | 0 | 187.65 | 0 | 275.88 | 0 | |
Receivables turnover | 0 | 4.82 | 0 | 4.12 | 0 | |
Payables turnover | 0 | 0.44 | 0 | 0.33 | 0 | |
Inventory turnover | 0 | 0.48 | 0 | 0.33 | 0 | |
ROE | 0 | 0.03 | 0 | 0.02 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ULTRACEMCO.NS Frequently Asked Questions
What is UltraTech Cement Limited stock symbol ?
UltraTech Cement Limited is a IN stock and trading under the symbol ULTRACEMCO.NS
What is UltraTech Cement Limited stock quote today ?
UltraTech Cement Limited stock price is $9363.95 today.
Is UltraTech Cement Limited stock public?
Yes, UltraTech Cement Limited is a publicly traded company.